Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
Wilmington DE specialty materials (NYSE: DD) at $12.4B 2024 revenue; Electronics business separation underway (semiconductor/advanced packaging materials), 2025 guidance $12.8-12.9B competing with Entegris and BASF.
DuPont de Nemours, Inc. is a Wilmington, Delaware-based specialty materials and chemicals company — publicly traded on the New York Stock Exchange (NYSE: DD) as an S&P 500 Materials component — providing advanced materials, specialty chemicals, and performance solutions for electronics, water treatment, safety applications, and industrial manufacturing through approximately 24,000 employees worldwide. In full year 2024, DuPont reported net sales of $12.4 billion (+3% year-over-year) and adjusted EPS of $4.07, with Q4 2024 net sales of $3.1 billion (+7%). For 2025, DuPont guided net sales of $12.8-12.9 billion with operating EBITDA of $3.325-3.375 billion. DuPont's defining strategic development of 2024-2025 is its announced separation into multiple independent companies: the Electronics business (semiconductor materials, advanced packaging materials, display technologies) is being separated as a standalone public company, targeting the multi-hundred-billion-dollar semiconductor materials market, while the remaining DuPont retains the Water & Protection and industrial specialty chemical businesses. This separation, when completed, will concentrate each business on its distinct end market — semiconductor advanced packaging materials (a high-growth AI chipmaking input) versus industrial protection and water purification applications. DuPont's heritage traces to 1802 when Éleuthère Irénée du Pont founded E.I. du Pont de Nemours to manufacture gunpowder, making it one of America's oldest continuously operating corporations.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.